Skip to main content
Clinical Trials/NCT04667325
NCT04667325CompletedNot Applicable

Evaluation de l'Observance thérapeutique à la spirométrie Incitative Chez Les Patients drépanocytaires

Centre Hospitalier Intercommunal Creteil1 site in 1 country15 target enrollmentStarted: January 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
15
Locations
1
Primary Endpoint
To take stock of the observance of sickle cell patients with inciting spirometry

Study Overview

Brief Summary

Sickle cell disease is one of the most common genetic diseases in the world. (1) It is characterized by the production of abnormal hemoglobin mainly responsible for vaso-occlusive clinical manifestations and chronic hemolysis with anemia. (2) It is therefore a chronic disease with major acute complications, such as acute chest syndrome. The treatment for this syndrome will be based on oxygenation, hydration and analgesia. At the physiotherapy level, we will have an action on the prevention and treatment of the syndrome by incentive spirometry. (3,4) In fact, it is currently the only physiotherapy treatment that has proven its effectiveness and is recommended for sickle cell patients. (3) As part of prevention, it is recommended to prescribe incentive spirometry during vaso-occlusive crisis. It has been shown to reduce the risk of atelectasis and significantly limit the risk of developing ACS. (5) In treatment, it makes it possible to regain normal chest amplification and therefore to allow ventilation of unventilated areas. (3.4) However, in order to increase therapeutic efficacy, patient compliance is essential.

Adherence to treatment is a major problem in chronic diseases. Currently, it is estimated that 80% of patients with chronic conditions do not sufficiently follow their therapy, which limits the optimization of benefits. (6) This is the case in sickle cell patients, especially with hydroxyurea which is their disease-modifying treatment. Lack of adherence is the most common cause of primary failure of this treatment.

During various treatments, we noticed the patients' lack of compliance with spirometry. Indeed, we explained to the patient how to do the incentive spirometry, so that he could practice it several times a day as recommended. When we returned the next day, or after a weekend, most of the time the patients had little or no observance. So I wanted to know if this concerns a majority of patients with sickle cell disease. Indeed, it appears important to assess compliance in these patients in order to improve the effectiveness of treatment and reduce the risk of ACS.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with sickle cell disease,
  • No opposition for participation in the protocol

Exclusion Criteria

  • Patients unable to answer the questionnaire due to linguistic or other problems
  • Patients under guardianship or curatorship

Outcomes

Primary Outcomes

To take stock of the observance of sickle cell patients with inciting spirometry

Time Frame: Through study completion, an everage of 10 minutes

Measuring compliance through the questionnaire

Secondary Outcomes

  • To take stock of patients' knowledge of their pathology and incentive spirometry(Through study completion, an everage of 10 minutes)
  • Measuring adherence to medical follow-up(Through study completion, an everage of 10 minutes)
  • Assessing the impact of the disease on quality of life(Through study completion, an everage of 10 minutes)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials